Search clinical trials for: CNMAu8

Total 4 results

Clene Nanomedicine

Active, not recruiting

An Open-Label Extension for the Phase 2 Study in Early Symptomatic Amyotrophic Lateral Sclerosis Patients on Stable Background Therapy to Assess Bioenergetic Catalysis With CNM-Au8 to Slow Disease Progression in ALS

Amyotrophic Lateral Sclerosis

Australia
Clene Nanomedicine
Massachusetts General Hospital

Available

Intermediate Expanded Access Protocol for ALS

Amyotrophic Lateral Sclerosis

United States
Clene Nanomedicine
National Institute of Neurological Disorders and Stroke (NINDS)

Available

Intermediate Expanded Access Protocol CNMAu8.EAP04

Amyotrophic Lateral Sclerosis | ALS | PALS
Clene Nanomedicine

Available

Intermediate Expanded Access Protocol (EAP) CNMAu8.EAP02

Amyotrophic Lateral Sclerosis

United States

3

Subscribe